[Histiocytosis of the Langerhans cells with cerebellar and pyramidal involvement. Response to treatment with chemotherapy].
Martínez-Fernández
E
E
Gil-Néciga
E
E
López-Domínguez
J M
JM
Casado-Chocán
J L
JL
Garzón
F
F
Franco
E
E
Abrio
M V
MV
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000150:complications / Q000175:diagnosis*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011712:Pyramidal Tracts / Q000473:pathology*; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone